These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 25367150)

  • 1. Rate-control drugs affect variability and irregularity measures of RR intervals in patients with permanent atrial fibrillation.
    Corino VD; Ulimoen SR; Enger S; Mainardi LT; Tveit A; Platonov PG
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):137-41. PubMed ID: 25367150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-blockade and A1-adenosine receptor agonist effects on atrial fibrillatory rate and atrioventricular conduction in patients with atrial fibrillation.
    Corino VD; Holmqvist F; Mainardi LT; Platonov PG
    Europace; 2014 Apr; 16(4):587-94. PubMed ID: 23989533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian variation of variability and irregularity of heart rate in patients with permanent atrial fibrillation: relation to symptoms and rate control drugs.
    Corino VD; Platonov PG; Enger S; Tveit A; Ulimoen SR
    Am J Physiol Heart Circ Physiol; 2015 Dec; 309(12):H2152-7. PubMed ID: 26497961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Troponin I levels in permanent atrial fibrillation-impact of rate control and exercise testing.
    Horjen AW; Ulimoen SR; Enger S; Norseth J; Seljeflot I; Arnesen H; Tveit A
    BMC Cardiovasc Disord; 2016 May; 16():79. PubMed ID: 27142292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?].
    Blagova OV; Nedostup AV
    Ter Arkh; 2006; 78(8):30-8. PubMed ID: 17078214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of four single-drug regimens on ventricular rate and arrhythmia-related symptoms in patients with permanent atrial fibrillation.
    Ulimoen SR; Enger S; Carlson J; Platonov PG; Pripp AH; Abdelnoor M; Arnesen H; Gjesdal K; Tveit A
    Am J Cardiol; 2013 Jan; 111(2):225-30. PubMed ID: 23111138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive assessment of the effect of beta blockers and calcium channel blockers on the AV node during permanent atrial fibrillation.
    Sandberg F; Corino VD; Mainardi LT; Ulimoen SR; Enger S; Tveit A; Platonov PG; Sörnmo L
    J Electrocardiol; 2015; 48(5):861-6. PubMed ID: 26275982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium channel blockers improve exercise capacity and reduce N-terminal Pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation.
    Ulimoen SR; Enger S; Pripp AH; Abdelnoor M; Arnesen H; Gjesdal K; Tveit A
    Eur Heart J; 2014 Feb; 35(8):517-24. PubMed ID: 24135831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive evaluation of the effect of metoprolol on the atrioventricular node during permanent atrial fibrillation.
    Corino VD; Sandberg F; Platonov PG; Mainardi LT; Ulimoen SR; Enger S; Tveit A; Sörnmo L
    Europace; 2014 Nov; 16 Suppl 4():iv129-iv134. PubMed ID: 25362163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved rate control reduces cardiac troponin T levels in permanent atrial fibrillation.
    Ulimoen SR; Enger S; Norseth J; Pripp AH; Abdelnoor M; Arnesen H; Gjesdal K; Tveit A
    Clin Cardiol; 2014 Jul; 37(7):422-7. PubMed ID: 24700386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate modulation drugs in atrial fibrillation: what is the clinical impact?
    Costea AI; Platonov PG
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):142-4. PubMed ID: 25431209
    [No Abstract]   [Full Text] [Related]  

  • 12. Diltiazem reduces levels of NT-proBNP and improves symptoms compared with metoprolol in patients with permanent atrial fibrillation.
    Enge K; Tveit A; Enger S; Onarheim S; Pripp AH; Rønningen PS; Solberg MG; Byrkjeland R; Andresen K; Halsen A; Aulie HA; Steinsvik T; Hall C; Ulimoen SR
    Eur Heart J Cardiovasc Pharmacother; 2024 Oct; 10(6):515-525. PubMed ID: 38702844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diltiazem vs. Metoprolol in the Management of Atrial Fibrillation or Flutter with Rapid Ventricular Rate in the Emergency Department.
    Fromm C; Suau SJ; Cohen V; Likourezos A; Jellinek-Cohen S; Rose J; Marshall J
    J Emerg Med; 2015 Aug; 49(2):175-82. PubMed ID: 25913166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter.
    Phillips BG; Gandhi AJ; Sanoski CA; Just VL; Bauman JL
    Pharmacotherapy; 1997; 17(6):1238-45. PubMed ID: 9399606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diltiazem versus metoprolol for the management of atrial fibrillation: A systematic review and meta-analysis.
    Jafri SH; Xu J; Warsi I; Cerecedo-Lopez CD
    Am J Emerg Med; 2021 Oct; 48():323-327. PubMed ID: 34274577
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.
    Swedberg K; Olsson LG; Charlesworth A; Cleland J; Hanrath P; Komajda M; Metra M; Torp-Pedersen C; Poole-Wilson P
    Eur Heart J; 2005 Jul; 26(13):1303-8. PubMed ID: 15767288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of the heart rate reserve in patients with permanent atrial fibrillation treated according to a strict rate-control strategy.
    De Schryver N; Scavée C; Marchandise S; Pasquet A; de Meester C; le Polain de Waroux JB
    Europace; 2014 Aug; 16(8):1125-30. PubMed ID: 24599938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy).
    Ruwald MH; Abu-Zeitone A; Jons C; Ruwald AC; McNitt S; Kutyifa V; Zareba W; Moss AJ
    J Am Coll Cardiol; 2013 Oct; 62(15):1343-50. PubMed ID: 23770172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous metoprolol versus diltiazem for rate control in noncardiac, nonthoracic postoperative atrial fibrillation.
    Personett HA; Smoot DL; Stollings JL; Sawyer M; Oyen LJ
    Ann Pharmacother; 2014 Mar; 48(3):314-9. PubMed ID: 24408816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium channel blockers for heart rate control in atrial fibrillation complicated by congestive heart failure.
    Heywood JT
    Can J Cardiol; 1995 Oct; 11(9):823-6. PubMed ID: 7585281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.